Funding for this research was provided by:
National Natural Science Foundation of China (No. 82102406)
Shanghai Municipal Science and Technology Major Project (HS2021SHZX001)
Shanghai Science and Technology Committee (21NL2600100)
Received: 7 April 2023
Accepted: 18 April 2023
First Online: 8 May 2023
: The trial has been reviewed and has received ethical approval from the Ethics Advisory Group of Huashan Hospital, Fudan University (approval number KY2022–508). Prior to undergoing any study-specific procedures, participants must provide signed and dated written informed consent to participate in this trial, and agree to the collection and use of their data. All methods were performed in accordance with the relevant guidelines and regulation.
: Not applicable.
: The authors declare no competing interests.